ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,352.85
0.11%
US Tech 100
18,573.20
0.30%
다우존스 지수
38,788.05
-0.03%
Bitcoin
70,031.87
0.54%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Immix Biopharma Inc (IMMX)

  7. Immix Biopharma Inc (IMMX) 뉴스

IMMX

Immix Biopharma (IMMX)

Immix Biopharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:IMMX
일자시간출처헤드라인심볼기업
2024/06/1022:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/06/1022:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/06/1021:30GlobeNewswire Inc.RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and PartnershipsNASDAQ:IMMXImmix Biopharma Inc
2024/06/0522:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/06/0522:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2205:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106:27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/2106:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1510:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1510:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2024/05/1005:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0807:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0623:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2024/02/0606:38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMMXImmix Biopharma Inc
2024/02/0606:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMMXImmix Biopharma Inc
2023/12/1308:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/11/2900:48InvestorsHub NewsWireImmix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient DosingNASDAQ:IMMXImmix Biopharma Inc
2023/11/1009:57Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMMXImmix Biopharma Inc
2023/11/1009:54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMMXImmix Biopharma Inc
2023/09/2913:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMMXImmix Biopharma Inc
2023/09/2605:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IMMXImmix Biopharma Inc
2023/09/1908:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/09/1607:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/09/1305:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
2023/08/3105:15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IMMXImmix Biopharma Inc
2023/08/2405:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMMXImmix Biopharma Inc
 검색 관련기사 보기:NASDAQ:IMMX

최근 히스토리

NYSE
AXP
American Express
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US100
US Tech 100
FX
USDJPY
US Dollar vs Yen
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
NYSE
CVX
Chevron
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
FX
USDGBP
US Dollar vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유